Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001826466-22-000138
Filing Date
2022-11-07
Accepted
2022-11-07 06:11:24
Documents
42
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 nika-20220630x10qa.htm   iXBRL 10-Q/A 376620
7 EXHIBIT 31-1 nika-202206630xex31d1.htm EX-31.1 7153
8 EXHIBIT 32-1 nika-202206630xex32d1.htm EX-32.1 3268
  Complete submission text file 0001826466-22-000138.txt   2299217

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nika-20220630.xsd EX-101.SCH 17347
3 XBRL CALCULATION FILE nika-20220630_cal.xml EX-101.CAL 24998
4 XBRL DEFINITION FILE nika-20220630_def.xml EX-101.DEF 70785
5 XBRL LABEL FILE nika-20220630_lab.xml EX-101.LAB 153103
6 XBRL PRESENTATION FILE nika-20220630_pre.xml EX-101.PRE 134831
36 EXTRACTED XBRL INSTANCE DOCUMENT nika-20220630x10qa_htm.xml XML 286705
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

EIN.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-56234 | Film No.: 221363606
SIC: 3790 Miscellaneous Transportation Equipment